Study of Histological Samples From Patients With Hereditary Haemorrhagic Telangiectasia
This trial is active, not recruiting.
|Condition||telangiectasia, hereditary hemorrhagic|
|Sponsor||Imperial College London|
|Start date||September 2008|
|End date||August 2020|
|Trial size||50 participants|
|Trial identifier||NCT00733655, IC/CLS5|
Hereditary Haemorrhagic Telangiectasia (HHT, also known as Osler-Weber-Rendu Syndrome) is an disease that leads to the development of dilated and fragile blood vessels. We propose to obtain small skin samples from patients with HHT in order to analyze the samples using histological methods, and study the properties of vascular endothelial cells derived from patients. We hypothesize that these cells will show altered growth, migration, and protein synthetic differences when compared to normal endothelial cells, which may be confirmed in single time point analyses in histological samples. We anticipate that that these findings may help to explain aspects of the HHT disease phenotype.
Male or female participants of any age.
Inclusion Criteria: - Patients with Hereditary Haemorrhagic Telangiectasia Exclusion Criteria: - Unable to provide informed consent
|Principal investigator||Claire L Shovlin|
Call for more information